Immune - Health Rising

A Fibromyalgia Autoimmune Subset Rears Its Head

by Cort Johnson | Nov 26, 2025 | Allodynia, Autoimmune, B-cells, Fibromyalgia and Pain, Homepage, Immune, Research, Small Fiber Neuropathy, T-cells

More evidence is presented that the most severely ill fibromyalgia patients have an autoimmune disease.

A Long COVID Autoimmune Subset Coming into View? (and Why ME/CFS May be Next)

by Cort Johnson | Nov 20, 2025 | Autoimmune, Brain, Brainstem, Homepage, Immune, Locus coeruleus, Norepinephrine, Pons

Solve ME Catalyst Award winner Dr. Iwasaki explains a subset of long COVID patients may have an autoimmune disease. Now she moves onto ME/CFS.

Low Brain Norepinephrine Levels in ME/CFS and Long COVID Pt. II: A ChatGPT Based Treatment Program

by Cort Johnson | Nov 16, 2025 | Autonomic Nervous System, Brain, Brainstem, Clonidine, CoQ10, D-Ribose, GLP-1, GLP-1 agonist, Guanfacine, Homepage, Ivabradine, Kaiser, L-carntine/Acetylcarnitine, Locus coeruleus, Mast cell activation syndrome, Mestinon, Neuroplasticity, Neuroplasticity, Norepinephrine, Pacing, Prefrontal Cortex, Propanolol, Rapamycin, Research, Stimulants, Urolithin A

Check out how ChatGPT thinks people with ME/CFS and long COVID might treat the low norepinephine brain findings in these diseases.

Role Reversal: Could a WEAKENED Fight/Flight Response Be Causing ME/CFS and Long COVID? The 2025 IACFS/ME Conference Pt. I

by Cort Johnson | Nov 11, 2025 | Astrocytes, Autonomic Nervous System, Brain, Brainstem, Dopamine, Energy Production, Homepage, Locus coeruleus, long COVID, Neuroinflammation, Neuroinflammation, Norepinephrine, Oxidative Stress, Research, Sleep

Low brain norepinephrine levels could explain many of the symptoms present in ME/CFS, long COVID and similar diseases.

The GLP-1 Agonist Boom in ME/CFS, FM and Long COVID: Insights, Using it, Trials Underway

by Cort Johnson | Nov 3, 2025 | COVID-19, Dempsey, Epstein-Barr Virus, GLP-1, Gut, Homepage, Immune, Inflammation, Kaufman, Mast cell activation syndrome, Mast cell activation syndrome, Neuroinflammation, Pathogens, POTS, RECOVER Initiative, Severe ME/CFS, Treatment

Complex, chronic illness experts discuss what GLP-1 agonists can and can't do in diseases like ME/CFS, long COVID, and POTS. Plus new long COVID trials.

PrecisionLife’s Bold Attempt to Break the Code on and Beat ME/CFS and Long COVID

by Cort Johnson | Oct 27, 2025 | Artificial Intelligence, COVID-19, Energy Production, Genetics, GWAS (Genome-Wide Association Study), Homepage, Low Dose Naltrexone, Metabolism, Monocytes, Oxidative Stress, Pathogens, Research, T-cells

Geoff’s Narration The GIST This is the next in a series of blogs exploring ongoing projects in ME/CFS, FM and long COVID. The first featured the RECOVER project’s next set of long COVID clinical trials. RECOVER’s 2nd Round of Long COVID...

Major Study Validates a Long COVID Autoimmune Subset

A Fibromyalgia Autoimmune Subset Rears Its Head

A Long COVID Autoimmune Subset Coming into View? (and Why ME/CFS May be Next)

Low Brain Norepinephrine Levels in ME/CFS and Long COVID Pt. II: A ChatGPT Based Treatment Program

Role Reversal: Could a WEAKENED Fight/Flight Response Be Causing ME/CFS and Long COVID? The 2025 IACFS/ME Conference Pt. I

The GLP-1 Agonist Boom in ME/CFS, FM and Long COVID: Insights, Using it, Trials Underway

PrecisionLife’s Bold Attempt to Break the Code on and Beat ME/CFS and Long COVID

Health Rising’s 2026 Spring Drive

Subscribe

Lives Interrupted

Lives Interrupted Latest Story

Lives Interrupted Stats

StudyME

Simmaron Research

ME/CFS & Fibromyalgia Treatment Room

May 12th - International ME/CFS & FM Awareness Day

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Thank you for signing up!

Pin It on Pinterest